Characteristics and laboratory data from four groups of non-diabetic Apoe−/− mice and STZ-induced diabetic Apoe−/− mice treated with or without dapagliflozin.

Non-diabetic mice that received vehicle, non-diabetic mice that received dapagliflozin, diabetic mice that received vehicle, diabetic mice that received dapagliflozin were measured. The values show mean ± SEM. dapagliflozin, sodium glucose co-transporter 2 inhibitor; SBP, systolic blood pressure; HbA1c, hemoglobin A1c; Total-C, total cholesterol; HDL-C, high-density lipoprotein cholesterol; GLP-1, glucagon like peptide-1; GIP, glucose-dependent insulinotropic polypeptide. One-way ANOVA followed by Tukey test:a,p b,p c,p Characteristics and laboratory data from four groups of non-diabetic Apoe−/− mice and STZ-induced diabetic Apoe−/− mice treated with or without dapagliflozin.